NEXGEL, INC. (NXGL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NEXGEL (NXGL) reported Q2 2026 revenue of $3.69M, up from $2.88M a year earlier, citing Celularity transaction growth and BioNX Surgical integration. The quarter showed a net loss of $2.87M, attributed to integration costs, intangible amortization, transaction expenses, and a SilverSeal inventory recall. Shares trade around $0.39, down 30% YTD.

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content

Cipher Digital (CIFR) shares dropped 11% to $11.53 after announcing plans to raise up to $1 billion via convertible notes. The notes, maturing in 2032, can be converted into cash or shares. Proceeds will fund projects like Barber Lake and expand high-performance computing. The company aims to limit dilution through capped call transactions.

African Rainbow Minerals (ARM) and Assore, controlled by the Motsepe and Sacco families respectively, are in a legal dispute over Assmang's management. ARM claims Assore's allegations lack merit and is seeking information for regulatory compliance. Assmang contributed R2.03bn to ARM's earnings in 2026, down 42% YoY. Both parties are still discussing Assmang's final dividend.

SentinelOne (S) shares fell 2.9% after announcing a $1.25B convertible note offering, potentially diluting shareholders. The company's stock is volatile, up 70.2% YTD, near its 52-week high. The offering may increase share count, impacting existing investors.

Strive (ASST) bought 3,311 Bitcoin for $280 million, its largest purchase since January, bringing total holdings to 32,773 BTC. CEO Matt Cole noted the purchase included $208 million in exercised warrants. Meanwhile, Strategy (MSTR) reduced its Bitcoin buying by 85% due to lower share sale proceeds and increased preferred-stock buybacks.